P239 Eradication of new pseudomonas aeruginosa isolates in adults with cystic fibrosis. (12th November 2019)
- Record Type:
- Journal Article
- Title:
- P239 Eradication of new pseudomonas aeruginosa isolates in adults with cystic fibrosis. (12th November 2019)
- Main Title:
- P239 Eradication of new pseudomonas aeruginosa isolates in adults with cystic fibrosis
- Authors:
- Boyes, WL
McVean, R
Bright-Thomas, RJ - Abstract:
- Abstract : Introduction: UK national CF registry data 2017 demonstrates that 44.5% of UK adults with CF are chronically colonised with Pseudomonas aeruginosa (PA). Chronic PA infection, once established, is usually impossible to eradicate and is associated with reduced life expectancy in CF. The aim of this study was to examine eradication rates, PA strain typing, and treatment regimens used following new isolations of PA at a large UK Adult CF Centre. Methods: Data was examined for all patients not known to have chronic PA infection attending a large regional UK CF Adult Centre isolating PA over a 7 year period. Results were gathered using the hospital online results system, clinic letters and national laboratory strain typing reports for 2012 – 2019. Successful eradication was defined as ≥3 sputum samples clear for PA over 6 months with no subsequent isolation of the same strain. Results: 168 patients, not considered chronically colonised with PA were identified. 72 of these isolated PA over the 7-year study period. 19 patients isolated PA on multiple separate occasions resulting in 91 individual PA infection episodes. Examining these episodes in detail: 55/91 episodes were new PA isolates. 46/55 (83.6%) of these successfully eradicated. Unique strains had the highest eradication rate at 20/21 (95.2%), followed by common environmental strains at 19/25 (76.0%) and epidemic (presumed transmissible) strains 3/5 (60.0%). Patients' first PA infection episodes had a higherAbstract : Introduction: UK national CF registry data 2017 demonstrates that 44.5% of UK adults with CF are chronically colonised with Pseudomonas aeruginosa (PA). Chronic PA infection, once established, is usually impossible to eradicate and is associated with reduced life expectancy in CF. The aim of this study was to examine eradication rates, PA strain typing, and treatment regimens used following new isolations of PA at a large UK Adult CF Centre. Methods: Data was examined for all patients not known to have chronic PA infection attending a large regional UK CF Adult Centre isolating PA over a 7 year period. Results were gathered using the hospital online results system, clinic letters and national laboratory strain typing reports for 2012 – 2019. Successful eradication was defined as ≥3 sputum samples clear for PA over 6 months with no subsequent isolation of the same strain. Results: 168 patients, not considered chronically colonised with PA were identified. 72 of these isolated PA over the 7-year study period. 19 patients isolated PA on multiple separate occasions resulting in 91 individual PA infection episodes. Examining these episodes in detail: 55/91 episodes were new PA isolates. 46/55 (83.6%) of these successfully eradicated. Unique strains had the highest eradication rate at 20/21 (95.2%), followed by common environmental strains at 19/25 (76.0%) and epidemic (presumed transmissible) strains 3/5 (60.0%). Patients' first PA infection episodes had a higher eradication rate 38/44 (86.4%) than second episodes 7/10 (70.0%). One patient had a third episode and successfully eradicated. 29/91 episodes were identified on strain typing as chronic PA infection: 15/29 (51.7%) were chronic on transfer to the unit and 14/29 (48.3%) had suppressed chronic infection due to long term inhaled antibiotics. The first episode of PA isolation was classed as a failure to eradicate and subsequent episodes as supressed. 7/91 episodes had incomplete data due to transfer or ongoing treatment. Discussion: In adults with CF, eradication rates of new PA isolates are extremely high at our centre but accurate strain typing is essential to distinguish acute from chronic PA infection and unique from epidemic strains. … (more)
- Is Part Of:
- Thorax. Volume 74(2019)Supplement 2
- Journal:
- Thorax
- Issue:
- Volume 74(2019)Supplement 2
- Issue Display:
- Volume 74, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 74
- Issue:
- 2
- Issue Sort Value:
- 2019-0074-0002-0000
- Page Start:
- A220
- Page End:
- A220
- Publication Date:
- 2019-11-12
- Subjects:
- Chest -- Diseases -- Periodicals
Thorax
Chest -- Diseases
Periodicals
Periodicals
617.54 - Journal URLs:
- http://thorax.bmjjournals.com/contents-by-date.0.shtml ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/thorax-2019-BTSabstracts2019.382 ↗
- Languages:
- English
- ISSNs:
- 0040-6376
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18381.xml